Both in Biotechnology
ProKidney vs Protalix BioTherapeutics
Over the past year PROK returned −60.0% and PLX returned +15.0%; their daily moves had a correlation of 0.19.
PROK −60.0% PLX +15.0%Growth of $1, one year, split-adjusted
| Metric | PROK | PLX |
|---|---|---|
| Price | $1.12 | $2.69 |
| Market cap | $234.1M | $216.7M |
| Today | +4.67% | +3.07% |
| 1 month | −30.0% | −1.5% |
| 6 months | −42.9% | +33.2% |
| Year to date | −50.0% | +49.4% |
| 1 year | −60.7% | +12.6% |
| Revenue growth (YoY) | −32.1% | +27.1% |
| Gross margin | 100.0% | 61.0% |
| Net margin | −18948.0% | 19.0% |
| P/E (TTM) | — | 11.4× |
| Price / sales | 286.1× | 2.7× |
| Net cash | $181.6M | $40.7M |
| Dividend yield | — | — |
| Volatility (60d) | 85.6% | 45.0% |
| Short % of float | 27.4% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).